September 15, 2014: Allergan, which has been fighting off hostile takeover attempts by Valeant and Pershing Square Capital Management, filed a Worker Adjustment and Retraining Notification (WARN) with the California Employment Development Department to cut 129 jobs.
September 15, 2014: Cambridge, Mass.-based biotech startup Scholar Rock has received $20 million in a Series A round of financing. The biotechnology company is dedicated to discovering and developing modulators that target protein growth factors in the disease environment.
September 15, 2014: Gilead Sciences was entering into non-exclusive licensing agreements with seven generic pharmaceutical manufacturers in India to make and sell its hepatitis C drug Sovaldi (sofusbuvir).
September 15, 2014: Pharma giant Roche has been hit by counterfeit drugmakers for the second time in a year, after the company said Friday it had found compromised vials of its blood cancer drug MabThera being sold in Germany.